Addition of long-acting beta2-agonists to inhaled corticosteroids versus same dose inhaled corticosteroids for chronic asthma in adults and children-Reference-Cited by-同舟云学术

Addition of long-acting beta2-agonists to inhaled corticosteroids versus same dose inhaled corticosteroids for chronic asthma in adults and children

Published:2010-05-12 Issue: Volume: Page:
ISSN:1465-1858
Container-title:Cochrane Database of Systematic Reviews
language:en
Short-container-title:

Author:

Ducharme Francine M¹,Ni Chroinin Muireann²,Greenstone Ilana³,Lasserson Toby J⁴

Affiliation:

1. University of Montreal; Research Centre, CHU Sainte-Justine and the Department of Pediatrics; 3175 Cote Sainte-Catherine Montreal Québec Canada H3T 1C5

2. Cork University Hospital; Division of Children's Services; Cork Ireland

3. Montreal Children's Hospital; 2300 Tupper St Montreal Canada H3H 1P3

4. St George's, University of London; Community Health Sciences; Cranmer Terrace London UK SW17 0RE

Publisher

Wiley

Subject

Pharmacology (medical)

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/14651858.CD005535.pub2/fullpdf

Reference632 articles.

1. Effect of formoterol on clinical parameters and lung functions in patients with bronchial asthma: a randomised controlled trial;Akpinarli;Archives of Disease in Childhood,1999

2. Salmeterol/fluticasone propionate (50/500 mug) in combination in a Diskus(TM) inhaler (Seretide(TM)) is effective and safe in the treatment of steroid-dependent asthma;Aubier;Respiratory Medicine,1999

3. Pieters W Ringdal N Aubier M Chapman KR Huskisson SC A new inhaler combination containing salmeterol and fluticasone propionate is well-tolerated in long-term use European Respiratory Journal 1998 P164

4. Cost effectiveness analysis of salmeterol/fluticasone propionate 50/500mcg vs fluticasone propionate 500mcg in patients with corticosteroid-dependent asthma;Pieters;Pharmacoeconomics,1999

5. Pieters WR Sondhi S Price MJ Thwaites RM Nyth A The cost effectiveness of salmeterol/fluticasone propionate 50/500 microgram combination inhaler versus fluticasone propionate 500 microgram in patients with chronic asthma European Respiratory Society; 1999 Oct 9-13; Madrid, Spain 1999 P2458

Cited by 98 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Stepwise Approach in Asthma Revisited 2023: Expert Panel Opinion of Turkish Guideline of Asthma Diagnosis and Management Group;Thoracic Research and Practice;2023-10-31

2. Addition of long-acting beta2 agonists or long-acting muscarinic antagonists versus doubling the dose of inhaled corticosteroids (ICS) in adolescents and adults with uncontrolled asthma with medium dose ICS: a systematic review and network meta-analysis;Cochrane Database of Systematic Reviews;2023-08-21

3. Optimizing asthma management: Role of long-acting muscarinic antagonists;Journal of Allergy and Clinical Immunology;2022-09

4. Retrospective observational study of asthma and chronic obstructive pulmonary disease prevalence and associated healthcare resource utilization in a large, integrated healthcare system;Baylor University Medical Center Proceedings;2022-07-19

5. Federal guidelines on diagnosis and treatment of bronchial asthma;PULMONOLOGIYA;2022-07-14